Search research articles
Contact Us
Filters
Showing results (101-110 of 112) with videos related to
Page
of 12
Sort By:
Anticancer Research
|
April 19, 2006
Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes
Sherko Kümmel, Holm Eggemann, Diana Lüftner, et al.
Gynecologic Oncology
|
January 6, 2016
Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)
Günter Emons, Christian Kurzeder, Barbara Schmalfeldt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 10, 2012
Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database
Carlos A Garcia-Etienne, Mariano Tomatis, Joerg Heil, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 6, 2021
Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)
Günter Emons, Jae-Weon Kim, Karin Weide, et al.
Breast Care (Basel, Switzerland)
|
June 15, 2022
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors
Rita K Schmutzler, Björn Schmitz-Luhn, Bettina Borisch, et al.
BMC Cancer
|
March 9, 2018
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
Christoph Engel, Kerstin Rhiem, Eric Hahnen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2022
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial
Jacobus Pfisterer, Florence Joly, Gunnar Kristensen, et al.
Geburtshilfe Und Frauenheilkunde
|
June 25, 2021
Perimenopause and Postmenopause - Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020)
Elisabeth C Inwald, Christian Albring, Erika Baum, et al.
Geburtshilfe Und Frauenheilkunde
|
October 27, 2018
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer
Günter Emons, Eric Steiner, Dirk Vordermark, et al.
Geburtshilfe Und Frauenheilkunde
|
August 17, 2023
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures
Günter Emons, Eric Steiner, Dirk Vordermark, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 112) with videos related to
Sort By:
Page
of 12
Anticancer Research
|
April 19, 2006
Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes
Sherko Kümmel, Holm Eggemann, Diana Lüftner, et al.
Gynecologic Oncology
|
January 6, 2016
Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8)
Günter Emons, Christian Kurzeder, Barbara Schmalfeldt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 10, 2012
Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database
Carlos A Garcia-Etienne, Mariano Tomatis, Joerg Heil, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 6, 2021
Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)
Günter Emons, Jae-Weon Kim, Karin Weide, et al.
Breast Care (Basel, Switzerland)
|
June 15, 2022
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors
Rita K Schmutzler, Björn Schmitz-Luhn, Bettina Borisch, et al.
BMC Cancer
|
March 9, 2018
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
Christoph Engel, Kerstin Rhiem, Eric Hahnen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2022
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial
Jacobus Pfisterer, Florence Joly, Gunnar Kristensen, et al.
Geburtshilfe Und Frauenheilkunde
|
June 25, 2021
Perimenopause and Postmenopause - Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020)
Elisabeth C Inwald, Christian Albring, Erika Baum, et al.
Geburtshilfe Und Frauenheilkunde
|
October 27, 2018
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer
Günter Emons, Eric Steiner, Dirk Vordermark, et al.
Geburtshilfe Und Frauenheilkunde
|
August 17, 2023
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures
Günter Emons, Eric Steiner, Dirk Vordermark, et al.
Page
of 12